These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1349419)

  • 21. [Efficacy of gliclazide in short and long-term therapy of older persons with noninsulin-dependent diabetes].
    Djurić DS; Djordjević PB; Micić D; Dragasević M
    Srp Arh Celok Lek; 1981 Nov; 109(11):1503-9. PubMed ID: 7051354
    [No Abstract]   [Full Text] [Related]  

  • 22. [[Early results of the treatment of diabetes with a (methyl-4-phenylsulfonyl)-1-[perhydrocyclopenta(C)pyrrolyl-2]-3-urea (gliclazide)].
    Montenero P; Leotta S
    Clin Ter; 1978 Aug; 86(4):319-35. PubMed ID: 737962
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diamicron through the European Association for the Study of Diabetes and the International Diabetes Federation congresses in Sydney in 1988].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1989; ():315-9. PubMed ID: 2668621
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term ambulatory treatment of diabetics with gliclazide].
    Parodi FA
    Clin Ter; 1979 Feb; 88(3):281-8. PubMed ID: 376219
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 26. The gliclazide poster world in Lisbon, 1989.
    Krall LP
    Am J Med; 1991 Jun; 90(6A):87S-88S. PubMed ID: 1908184
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study.
    Huang Y; Abdelmoneim AS; Light P; Qiu W; Simpson SH
    J Diabetes Complications; 2015 Mar; 29(2):196-202. PubMed ID: 25534984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A multicenter clinic study of slow-release-gliclazide in type 2 diabetes mellitus].
    Jia WP; Ning G; Gao X; Yan L; Yang HZ; Li M; Hong J; Lu ZQ; Cheng H; Qi YQ; Li ZW; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2636-9. PubMed ID: 16321325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)].
    Canivet J
    Therapeutique; 1972; 48(7):457-62. PubMed ID: 4640264
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 31. Long term improvement in insulin response with gliclazide treatment.
    Bodansky HJ; Medback S; Cudworth AG; Rees LH; de Silva RS
    Diabete Metab; 1982 Dec; 8(4):319-22. PubMed ID: 6761187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI; Morozova TP; Chachiashvili MV
    Sov Med; 1987; (7):21-2. PubMed ID: 3317910
    [No Abstract]   [Full Text] [Related]  

  • 33. [A new therapeutic approach to diabetes. Long-term survey].
    Charbonnel B
    Sem Hop Ther; 1977 Nov; 53(9):460-5. PubMed ID: 341321
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral treatment of diabetes mellitus: the contribution of gliclazide. Proceedings of a symposium, September 23, 1989, Lisbon, Portugal.
    Am J Med; 1991 Jun; 90(6A):1S-88S. PubMed ID: 1872300
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of acetylsalicylic acid on thrombocyte function in patients with diabetes mellitus (review of the literature)].
    Gendeleka GF; Gruzina EA
    Vrach Delo; 1987 Jan; (1):100-5. PubMed ID: 3564399
    [No Abstract]   [Full Text] [Related]  

  • 36. New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications.
    McGuire DK; Inzucchi SE
    Circulation; 2008 Jan; 117(3):440-9. PubMed ID: 18212301
    [No Abstract]   [Full Text] [Related]  

  • 37. [Important points and problems in insulin therapy of diabetes mellitus].
    Shichiri M
    Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):395-9. PubMed ID: 7751776
    [No Abstract]   [Full Text] [Related]  

  • 38. The emerging role of ACE inhibitors in diabetes: from theory to therapeutic management.
    Yudkin JS
    J Diabetes Complications; 1996; 10(3):129-32. PubMed ID: 8807456
    [No Abstract]   [Full Text] [Related]  

  • 39. A case for oral insulin therapy in the prevention of diabetic micro- and macroangiopathy.
    Gwinup G; Elias AN; Vaziri ND
    Int J Artif Organs; 1990 Jul; 13(7):393-5. PubMed ID: 2205590
    [No Abstract]   [Full Text] [Related]  

  • 40. Vascular protection with fibroblast growth factor 21 in diabetes: its potential beyond glucose and lipid control.
    Liu MH
    Int J Cardiol; 2015 Nov; 199():403-4. PubMed ID: 26253049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.